Page last updated: 2024-11-06

diflorasone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Diflorasone is a potent synthetic corticosteroid that is used topically to treat inflammatory skin conditions such as eczema, psoriasis, and dermatitis. It works by suppressing the immune system and reducing inflammation. Diflorasone is typically applied to the affected area once or twice daily. It is available in a variety of formulations, including creams, ointments, lotions, and gels. Diflorasone is generally well-tolerated, but side effects can occur, such as skin irritation, burning, itching, and dryness. It is important to use diflorasone as directed by your doctor and to avoid contact with the eyes and mouth. Diflorasone is not recommended for use in pregnant or breastfeeding women, as it can be absorbed through the skin and potentially harm the developing fetus or infant.'

diflorasone: RN given refers to (6alpha,11beta,16beta)-isomer; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

diflorasone : The 16beta-analogue of flumethasone. It is used as the 17,21-diacetate as a topical anti-inflammatory and antipruritic in the treatment of various skin disorders. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID71415
CHEBI ID59750
SCHEMBL ID4555
MeSH IDM0424431

Synonyms (46)

Synonym
AC-2167
diflorasone
(6alpha,11beta,16beta)-6,9-difluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione
DB00223
diflorasonum [inn-latin]
einecs 219-875-7
6alpha,9-difluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione
diflorasone [inn:ban]
diflorasona [inn-spanish]
u 34865
CHEBI:59750 ,
diflorasona
diflorasonum
murode
6a,9a-difluoro-16b-methylprednisolone
(6s,8s,9r,10s,11s,13s,14s,16s,17r)-6,9-difluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
2557-49-5
D07827
murode (tn)
diflorasone (inn)
unii-t2dhj9645w
t2dhj9645w ,
S5360
diflorasone [who-dd]
diflorasone [vandf]
diflorasone [mi]
6.alpha.,9-difluoro-11.beta.,17,21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione
diflorasone [inn]
SCHEMBL4555
Q-101394
AKOS025401541
(1r,2s,8s,10s,11s,13s,14r,15s,17s)-1,8-difluoro-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,13,15-trimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-5-one
diflorasone; (6alpha,11beta,16beta)-6,9-difluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione; pregna-1,4-diene-3,20-dione, 6alpha,9-difluoro-11beta,17,21-trihydroxy-16beta-methyl- (8ci)
CS-0017488
HY-A0158
Q5275451
AS-15781
BCP29719
CCG-268770
[2-(cyclohexylthio)-1h-benzimidazol-1-yl]-aceticacid
(1r,2s,3as,3bs,5s,9as,9br,10s,11as)-5,9b-difluoro-1,10-dihydroxy-1-(2-hydroxyacetyl)-2,9a,11a-trimethyl-1h,2h,3h,3ah,3bh,4h,5h,7h,9ah,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-7-one
EN300-19744559
diflorasonum (inn-latin)
d07ac10
diflorasona (inn-spanish)
DTXSID201036185

Research Excerpts

Treatment

ExcerptReferenceRelevance
"Treatment with diflorasone diacetate ointment and cream (0.05%) was strikingly successful in a multicenter clinical trial involving 4,651 patients in total suffering from various corticosteroid-sensitive dermatoses. "( [Topical treatment of glucocorticoid-sensitive dermatoses with diflorasone diacetate].
Rozman, TA, 1986
)
0.86

Bioavailability

ExcerptReferenceRelevance
" The molecular structure of diflorasone-17,21-diacetate and the specific pharmaceutical properties of the ointment and cream evidently guarantee a good bioavailability of the glucocorticosteroid in the skin."( [Topical treatment of glucocorticoid-sensitive dermatoses with diflorasone diacetate].
Rozman, TA, 1986
)
0.8
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
anti-inflammatory drugA substance that reduces or suppresses inflammation.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (9)

ClassDescription
11beta-hydroxy steroidAny 11-hydroxy steroid in which the hydroxy group at position 11 has beta- configuration.
20-oxo steroidAn oxo steroid carrying an oxo group at position 20.
17alpha-hydroxy steroidThe alpha-stereoisomer of 17-hydroxy steroid.
fluorinated steroidA steroid which is substituted with one or more fluorine atoms in any position.
glucocorticoidGlucocorticoids are a class of steroid hormones that regulate a variety of physiological processes, in particular control of the concentration of glucose in blood.
21-hydroxy steroid
3-oxo-Delta(1),Delta(4)-steroidA 3-oxo-Delta(1) steroid containing an additional double bond between positions 4 and 5.
primary alpha-hydroxy ketoneAn alpha-hydroxy ketone in which the carbonyl group and the hydroxy group are linked by a -CH2 (methylene) group.
tertiary alpha-hydroxy ketoneAn alpha-hydroxy ketone in which the carbonyl group and the hydroxy group are linked by a carbon bearing two organyl groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (38)

TimeframeStudies, This Drug (%)All Drugs %
pre-199021 (55.26)18.7374
1990's8 (21.05)18.2507
2000's7 (18.42)29.6817
2010's2 (5.26)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 51.75

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index51.75 (24.57)
Research Supply Index4.13 (2.92)
Research Growth Index4.11 (4.65)
Search Engine Demand Index85.29 (26.88)
Search Engine Supply Index2.08 (0.95)

This Compound (51.75)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials20 (48.78%)5.53%
Reviews0 (0.00%)6.00%
Case Studies6 (14.63%)4.05%
Observational0 (0.00%)0.25%
Other15 (36.59%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]